HemaCare Co. (OTCMKTS:HEMA – Get Free Report) traded up 0.6% during trading on Wednesday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares traded hands during trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Trading Up 0.6 %
The business has a fifty day moving average price of $25.31 and a 200 day moving average price of $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- How to Invest in Biotech Stocks
- 3 Must-Have ETFs Set to Dominate This Quarter
- Why Are These Companies Considered Blue Chips?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- ESG Stocks, What Investors Should Know
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
